These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8225934)

  • 1. Treatment of resistant akathisia with ECT--a case report.
    Caspi N; Levine J
    Isr J Psychiatry Relat Sci; 1993; 30(3):175-8. PubMed ID: 8225934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of neuroleptic-induced unilateral akathisia with periodic limb movements in the opposite side during sleep.
    Yamashita H; Horiguchi J; Mizuno S; Kuramoto Y; Yamawaki S; Inami Y
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):291-3. PubMed ID: 10459715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy for persistent neuroleptic-induced akathisia and parkinsonism: a case report.
    Hermesh H; Aizenberg D; Friedberg G; Lapidot M; Munitz H
    Biol Psychiatry; 1992 Feb; 31(4):407-11. PubMed ID: 1348431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
    Flint AJ; Rifat SL
    Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Nothdurfter C; Eser D; Schüle C; Zwanzger P; Marcuse A; Noack I; Möller HJ; Rupprecht R; Baghai TC
    World J Biol Psychiatry; 2006; 7(3):162-70. PubMed ID: 16861142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Perphenazine enanthate. Results of a 1-year open multicenter study].
    Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
    Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced akathisia and suicidal tendencies in psychotic patients.
    Kasantikul D
    J Med Assoc Thai; 1998 Jul; 81(7):551-4. PubMed ID: 9676095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technic and role of neuroleptic treatment with perphenazine in psychiatry].
    Ropert R
    Psychopharmacologie; 1971; ():71-82. PubMed ID: 5162009
    [No Abstract]   [Full Text] [Related]  

  • 14. Nocturnal myoclonus observed in a patient with neuroleptic-induced akathisia.
    Nishimatsu O; Horiguchi J; Inami Y; Innami T; Sasaki A; Kondo K
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):121-6. PubMed ID: 1353123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The augmentation of clozapine treatment with electroconvulsive therapy.
    Gazdag G; Kocsis-Ficzere N; Tolna J
    Ideggyogy Sz; 2006 Jul; 59(7-8):261-7. PubMed ID: 17076304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive monotherapy in the treatment of acute confusion psychosis. A case report.
    Neuhaus AH; Katchanov J; Opgen-Rhein C; Neu P; Jockers-Scherübl MC
    Pharmacopsychiatry; 2005 Nov; 38(6):330-2. PubMed ID: 16342009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akathisia and an unusual symptomatic treatment: a case report.
    Back I; Taubert M
    Palliat Med; 2007 Dec; 21(8):713-5. PubMed ID: 18073258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of neuroleptic malignant syndrome and serotonin disturbance.
    Young C
    J Clin Psychopharmacol; 1997 Feb; 17(1):65-6. PubMed ID: 9004069
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxetine and akathisia.
    Adler LA; Angrist BM
    Biol Psychiatry; 1995 Mar; 37(5):336-7. PubMed ID: 7748986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.